Company Profile

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE606.70-2.5 (-0.41 % )
PREV CLOSE (Rs.) 609.20
OPEN PRICE (Rs.) 606.00
BID PRICE (QTY) 606.70 (5 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 238
TODAY'S LOW / HIGH (Rs.)601.05 611.25
52 WK LOW / HIGH (Rs.)571.5 809
NSE610.05 3.35 (+0.55 % )
PREV CLOSE(Rs.) 606.70
OPEN PRICE (Rs.) 605.10
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 610.05 (153 )
VOLUME 3172
TODAY'S LOW / HIGH(Rs.) 602.80 615.00
52 WK LOW / HIGH (Rs.)572.5 812

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 1.44751
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 38.61
ROCE (%) 35.45
Incorporation Year : 2007

Management Info :

- Chairman Amit Indubhushan Bakshi - Managing Director

Registered Office :

Address : 8th Floor, Commerce House I V,Beside Shell Petrol Pump,100 Feet Road, Prahladnagar,
Ahmedabad,
Gujarat-380015

Phone : 079 3045 1111

Website : www.eris.co.in

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
18Apr04-18-2019$ Announcement under Regulation 30 (LODR)-Updates on Acquisition Announcement under Regulati
Dear Sir/Madam, We refer to our intimation dated 6th April, 2019, regarding consolidation of shareholding in the subsidiary, Kinedex Healthcare Private Limited by the Company. It is hereby notified that the transaction has achieved closure. This is for your information and record.
Dear Sir/Madam, We refer to our intimation dated 6th April,..
12Apr04-12-2019$ Foreclosure / Pre-Payment Of 'Loan Facility Agreements' Foreclosure / Pre-Payment O
Dear Sir/Madam, The Company hereby notifies having pre-paid the entire loan facility obtained from Axis bank Limited (Lender). The Loan Facility Agreements dated 30th November, 2017 with Axis bank Limited therefore stand closed / terminated. Thanking You
Dear Sir/Madam, The Company hereby notifies having pre-paid..
19Mar03-19-2019$ Announcement under Regulation 30 (LODR)-Resignation of Director Announcement under Regulati
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, It is hereby informed that Mr. Himanshu Shah, Executive Director of the company has resigned from the membership of the Board. The said resignation shall come into effect from the close of the business hours on 16th July, 2019.
In accordance with the requirements of Regulation 30 and other..
18Feb02-18-2019$ Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Announcement under Regulati
It is hereby informed that an allotment of 2161 equity shares of Re. 1/- each at a premium of Rs. 450.04/- per share has been made on 18.02.2019, pursuant to exercise of options under its ESOP-2017 Scheme. The paid up share capital of the Company has accordingly been increased from Rs. 13,75,17,622/- (13,75,17,622 equity shares of Re. 1/- each) to Rs. 13,75,19,783/- (13,75,19,783 equity shares of Re. 1/- each).
It is hereby informed that an allotment of 2161 equity shares o..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit788.772936.55
Gross Profit 872.68 3118.89
Operating Profit 1007.553441.1
Net Sales 2308.037606.01
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 7392.30 (2.83%)
M.Cap ( in Cr)
15708.12
Procter&Gamble Healt (BSE)
 4342.55 (3.17%)
M.Cap ( in Cr)
7208.36
Astrazeneca Pharma I (BSE)
 2343.00 (4.79%)
M.Cap ( in Cr)
5857.50
Piramal Enterprises (BSE)
 2133.40 (4.28%)
M.Cap ( in Cr)
42380.15
Pfizer (BSE)
 3003.70 (0.76%)
M.Cap ( in Cr)
13741.25
Shareholding Pattern More
PROMOTERS 56.1 %
NON-INSTITUTION 24.11 %
MUTUAL FUNDS/UTI 11.05 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested